BRPI0919241A8 - processo para fabricação de compostos de quinolona - Google Patents

processo para fabricação de compostos de quinolona

Info

Publication number
BRPI0919241A8
BRPI0919241A8 BRPI0919241A BRPI0919241A BRPI0919241A8 BR PI0919241 A8 BRPI0919241 A8 BR PI0919241A8 BR PI0919241 A BRPI0919241 A BR PI0919241A BR PI0919241 A BRPI0919241 A BR PI0919241A BR PI0919241 A8 BRPI0919241 A8 BR PI0919241A8
Authority
BR
Brazil
Prior art keywords
manufacturing
quinolone compounds
quinolone
compounds
manufacturing quinolone
Prior art date
Application number
BRPI0919241A
Other languages
English (en)
Inventor
Johnson Graham
M Reeve Maxwell
Hanselmann Roger
Original Assignee
Rib X Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rib X Pharmaceuticals Inc filed Critical Rib X Pharmaceuticals Inc
Publication of BRPI0919241A2 publication Critical patent/BRPI0919241A2/pt
Publication of BRPI0919241A8 publication Critical patent/BRPI0919241A8/pt
Publication of BRPI0919241B1 publication Critical patent/BRPI0919241B1/pt
Publication of BRPI0919241B8 publication Critical patent/BRPI0919241B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/027—Gearboxes; Mounting gearing therein characterised by means for venting gearboxes, e.g. air breathers
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/037—Gearboxes for accommodating differential gearings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H48/00—Differential gearings
    • F16H48/06—Differential gearings with gears having orbital motion
    • F16H48/08—Differential gearings with gears having orbital motion comprising bevel gears
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/0457—Splash lubrication
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/048—Type of gearings to be lubricated, cooled or heated
    • F16H57/0482—Gearings with gears having orbital motion
    • F16H57/0483—Axle or inter-axle differentials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/19—Gearing
    • Y10T74/19642—Directly cooperating gears
    • Y10T74/19688—Bevel
    • Y10T74/19693—Motor vehicle drive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/21—Elements
    • Y10T74/2186—Gear casings
    • Y10T74/2188—Axle and torque tubes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
BRPI0919241A 2008-09-24 2009-09-23 processo para fabricação de compostos de quinolona, e composição compreendendo composto de quinolona BRPI0919241B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24
US61/194,083 2008-09-24
PCT/US2009/005276 WO2010036329A2 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds

Publications (4)

Publication Number Publication Date
BRPI0919241A2 BRPI0919241A2 (pt) 2016-06-21
BRPI0919241A8 true BRPI0919241A8 (pt) 2017-10-17
BRPI0919241B1 BRPI0919241B1 (pt) 2020-05-12
BRPI0919241B8 BRPI0919241B8 (pt) 2021-05-25

Family

ID=42060333

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919241A BRPI0919241B8 (pt) 2008-09-24 2009-09-23 processo para fabricação de compostos de quinolona, e composição compreendendo composto de quinolona

Country Status (28)

Country Link
US (3) US8497378B2 (pt)
EP (3) EP3766876B8 (pt)
JP (2) JP6013734B2 (pt)
KR (3) KR101775304B1 (pt)
CN (2) CN102164912B (pt)
AU (1) AU2009297085B2 (pt)
BR (1) BRPI0919241B8 (pt)
CA (1) CA2738236C (pt)
CY (2) CY1123658T1 (pt)
DK (2) DK2346855T3 (pt)
ES (3) ES2826273T3 (pt)
FI (2) FI3766876T3 (pt)
HK (1) HK1214243A1 (pt)
HR (1) HRP20201879T1 (pt)
HU (2) HUE052219T2 (pt)
IL (1) IL211845A (pt)
LT (3) LT3766876T (pt)
MX (3) MX2011003122A (pt)
NL (1) NL301091I2 (pt)
NO (1) NO2021006I1 (pt)
PL (2) PL3766876T3 (pt)
PT (1) PT3214083T (pt)
RS (1) RS61194B1 (pt)
RU (1) RU2546667C2 (pt)
SG (1) SG10201605492YA (pt)
SI (1) SI3214083T1 (pt)
SM (1) SMT202000690T1 (pt)
WO (1) WO2010036329A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
PT3214083T (pt) * 2008-09-24 2020-12-04 Melinta Subsidiary Corp Processo de preparação compostos de quinolona
WO2014152317A2 (en) * 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating gonorrhea infections using quinolone antibiotics
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
JP6813665B2 (ja) 2017-03-31 2021-01-13 富士フイルム株式会社 4−ピリドン化合物またはその塩、それを含む医薬組成物および剤
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
ES2200439T3 (es) 1995-09-22 2004-03-01 Wakunaga Pharmaceutical Co., Ltd. Intermedios para utilizar en la preparacion de nuevos derivados del acido piridonocarboxilico o sus sales.
MXPA02000103A (es) * 1999-07-01 2003-07-21 Wakunaga Pharma Co Ltd Derivado de acido quinolin carboxilico o sales del mismo.
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
EP1789392A2 (en) 2004-07-30 2007-05-30 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
US7728143B2 (en) 2004-10-08 2010-06-01 Abbott Laboratories Salt and crystalline forms thereof of a drug
SI1868581T1 (sl) 2005-04-11 2012-06-29 Abbott Lab Farmacevtski sestavki z izboljšanim profilom topnosti za slabo topna zdravila
PT3214083T (pt) 2008-09-24 2020-12-04 Melinta Subsidiary Corp Processo de preparação compostos de quinolona

Also Published As

Publication number Publication date
CN105001207A (zh) 2015-10-28
CY1123658T1 (el) 2021-05-05
EP2346855A2 (en) 2011-07-27
EP3766876B1 (en) 2023-09-13
AU2009297085B2 (en) 2015-07-09
US8497378B2 (en) 2013-07-30
NL301091I2 (nl) 2021-08-03
BRPI0919241B8 (pt) 2021-05-25
FIC20210002I1 (fi) 2021-02-16
PT3214083T (pt) 2020-12-04
LTC3214083I2 (lt) 2022-06-27
RU2011116052A (ru) 2012-10-27
US20120041208A1 (en) 2012-02-16
SMT202000690T1 (it) 2021-01-05
IL211845A0 (en) 2011-06-30
CY2021004I2 (el) 2021-05-05
MX377930B (es) 2025-03-10
FI3766876T3 (fi) 2023-12-05
IL211845A (en) 2017-03-30
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
CA2738236C (en) 2016-11-15
ES2826273T3 (es) 2021-05-17
EP3214083A1 (en) 2017-09-06
HK1244481A1 (en) 2018-08-10
USRE46617E1 (en) 2017-11-28
US20140171648A1 (en) 2014-06-19
CN102164912B (zh) 2015-08-19
HRP20201879T1 (hr) 2021-01-22
BRPI0919241A2 (pt) 2016-06-21
NL301091I1 (nl) 2021-02-10
HUS2100004I1 (hu) 2021-03-01
PL3214083T3 (pl) 2021-04-06
HK1214243A1 (zh) 2016-07-22
PL3766876T3 (pl) 2024-04-02
SI3214083T1 (sl) 2021-02-26
EP3214083B1 (en) 2020-09-16
CN102164912A (zh) 2011-08-24
NO2021006I1 (no) 2021-02-15
EP3766876A1 (en) 2021-01-20
US8871938B2 (en) 2014-10-28
LTPA2021002I1 (lt) 2021-03-10
KR20160116020A (ko) 2016-10-06
ES2966093T3 (es) 2024-04-18
BRPI0919241B1 (pt) 2020-05-12
MX2011003122A (es) 2011-07-20
CY2021004I1 (el) 2021-05-05
WO2010036329A3 (en) 2010-07-01
CA2738236A1 (en) 2010-04-01
MX2020009790A (es) 2020-10-12
JP6013734B2 (ja) 2016-10-25
EP3766876B8 (en) 2023-10-18
SG10201605492YA (en) 2016-09-29
EP2346855A4 (en) 2012-07-04
DK2346855T3 (en) 2017-07-24
KR101775304B1 (ko) 2017-09-05
LT3766876T (lt) 2023-12-11
ES2629466T3 (es) 2017-08-09
HUE052219T2 (hu) 2021-04-28
LT3214083T (lt) 2021-01-25
JP2015178515A (ja) 2015-10-08
RS61194B1 (sr) 2021-01-29
AU2009297085A1 (en) 2010-04-01
KR20170039758A (ko) 2017-04-11
EP2346855B1 (en) 2017-04-05
JP2012508161A (ja) 2012-04-05
DK3214083T3 (da) 2020-12-07
WO2010036329A2 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
BRPI0819659A2 (pt) Processo para produção de álcool
BRPI0821944A2 (pt) Processo
PT2121578T (pt) Processo de preparação de ácido 5-bifenil-4-amino-2-metil-pentanoico
BRPI0919868A2 (pt) processo
BRPI0814291A2 (pt) Processo para produção de alcoóis
BRPI0918349A2 (pt) Processo para preparar dióxido de divinilareno
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0915017A2 (pt) Processo para a produção de álcool
BRPI0921374A2 (pt) processo
BRPI0919241A2 (pt) processo de fabricação de compostos de quinolona
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI1014911A2 (pt) processo para fabricação de resinas carregadas
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0922490A2 (pt) Método para produção de beta-santaleno
PT2165971T (pt) Processo de hidrotratamento
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BR112012000098A2 (pt) Processo para identificação de compostos para tratar câncer
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0921420A2 (pt) processo para preparar compostos
BRPI1006478A2 (pt) processo de fabricação de poliamida
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BRPI1014267A2 (pt) processo para a carbonitrificação
BRPI0909393A2 (pt) processo para a preparação de polibutadieno
BRPI1013830A2 (pt) Processo para a iodação de compostos aromáticos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MELINTA THERAPEUTICS, INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: MELINTA SUBSIDIARY CORP. (US)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: MELINTA THERAPEUTICS, INC. (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.1 NA RPI NO 2510 DE 12/02/2019 POR TER SIDO INDEVIDA.

B25D Requested change of name of applicant approved

Owner name: MELINTA SUBSIDIARY CORP (US)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/09/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF